Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
8.30
-0.85 (-9.29%)
May 8, 2026, 4:00 PM EDT - Market closed
Armata Pharmaceuticals Employees
Armata Pharmaceuticals had 60 employees as of December 31, 2024. The number of employees decreased by 6 or -9.09% compared to the previous year.
Employees
60
Change (1Y)
-6
Growth (1Y)
-9.09%
Revenue / Employee
$81,733
Profits / Employee
-$2,896,650
Market Cap
304.57M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 60 | -6 | -9.09% | 60 | 0 |
| Dec 31, 2023 | 66 | -9 | -12.00% | 66 | 0 |
| Dec 31, 2022 | 75 | 4 | 5.63% | 72 | 3 |
| Dec 31, 2021 | 71 | 9 | 14.52% | 69 | 2 |
| Dec 31, 2020 | 62 | 24 | 63.16% | 59 | 3 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Bicycle Therapeutics | 288 |
| Abeona Therapeutics | 226 |
| Niagen Bioscience | 117 |
| Silence Therapeutics | 88 |
| Lineage Cell Therapeutics | 77 |
| Rezolute | 75 |
| Immuneering | 53 |
| Compass Therapeutics | 39 |
ARMP News
- 1 day ago - Armata Pharmaceuticals secures FDA Fast Track Designation for AP-SA02 - TheFly
- 1 day ago - Armata Pharmaceuticals Secures FDA Fast Track Designation for AP-SA02 - PRNewsWire
- 4 days ago - Armata Pharmaceuticals Announces Structural Biology Publication in "Communications Biology" - PRNewsWire
- 11 days ago - Armata Pharmaceuticals Announces Appointment of Biopharmaceutical Commercial Executive Daniel B. Gilmer, Ph.D. - PRNewsWire
- 4 weeks ago - Armata Pharmaceuticals price target raised to $20 from $15 at JonesResearch - TheFly
- 6 weeks ago - Armata Pharmaceuticals reports Q4 EPS ($3.42) vs. (23c) last year - TheFly
- 6 weeks ago - Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2025 Financial Results - PRNewsWire
- 7 weeks ago - Armata Pharmaceuticals delays announcement of Q4, FY25 results - TheFly